- ►annals.org [PDF] F Grodstein, JAE Manson, GA Colditz, WC … - Annals of Internal Medicine, 2000 - Am Coll Physicians Background: Most primary prevention studies have found that long-term users of
postmenopausal hormone therapy are at lower risk for coronary events, but
numerous questions remain. An ad- verse influence of hormone therapy on ... Cited by 728 - Related articles - BL Direct - All 16 versions
- ►vcu.edu [PDF] DM Herrington, DM Reboussin, KB Brosnihan, … - New England Journal of Medicine, 2000 - content.nejm.org Results Estrogen and estrogen plus medroxyprogesterone acetate produced
significant reductions in low-density lipoprotein cholesterol levels (9.4
percent and 16.5 percent, respectively) and significant increases in high- ... Cited by 1182 - Related articles - BL Direct - All 12 versions
- ►annals.org [PDF] F Grodstein, JAE Manson, MJ Stampfer - Annals of Internal Medicine, 2001 - Am Coll Physicians Background: The Heart and Estrogen/progestin Replacement Study (HERS) was the
first randomized clinical trial of combined hormone therapy and secondary
prevention of coronary events. The trial had overall null results but ... Cited by 312 - Related articles - All 8 versions
- ►annals.org [PDF] HN Hodis, WJ Mack, RA Lobo, D Shoupe, A … - Annals of internal medicine, 2001 - Am Coll Physicians Background: Although observational studies suggest that estro- gen replacement
therapy (ERT) reduces cardiovascular morbidity and mortality in postmenopausal
women, use of unopposed ERT for prevention of coronary heart disease in ... Cited by 396 - Related articles - All 8 versions
- ►oxfordjournals.org TS Mikkola, TB Clarkson - Cardiovascular research, 2002 - cardiovascres.oxfordjournals.org There is strong evidence from both human and nonhuman primate studies supporting
the conclusion that estrogen deficiency increases the progression of
atherosclerosis. More controversial is the conclusion that postmenopausal ... Cited by 255 - Related articles - All 8 versions
- ►ama-assn.org [PDF] S Hulley, D Grady, T Bush, C Furberg, D … - Jama, 1998 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 4388 - Related articles - BL Direct - All 15 versions
- ►wisc.edu [PDF] JAE Manson, J Hsia, KC Johnson, JE Rossouw, … - The New England journal of medicine, 2003 - nejm.highwire.org From the Division of Preventive Medicine, Brigham and Women's Hospital and Har-
vard Medical School, Boston (JEM); the Department of Medicine, George Washing-
ton University, Washington, DC (JH); the Department of Preventive Medicine, ... Cited by 899 - Related articles - BL Direct - All 22 versions
- ►udl.es [PDF] CM Viscoli, LM Brass, WN Kernan, PM Sarrel, … - The New England journal of medicine, 2001 - nejm.highwire.org N Engl J Med, Vol. 345, No. 17 · October 25, 2001 · www.nejm.org · ...
CLINICAL TRIAL OF ESTROGEN-REPLACEMENT THERAPY AFTER ISCHEMIC STROKE ... A
CLINICAL TRIAL OF ESTROGEN-REPLACEMENT THERAPY AFTER ISCHEMIC STROKE Cited by 656 - Related articles - BL Direct - All 12 versions
- ►ku.dk [PDF] E Barrett-Connor, D Grady - Annual Review of Public Health, 1998 - Annual Reviews ▪ Abstract Multiple observational studies suggest a marked reduction in risk
of coronary heart disease (CHD) associated with postmenopausal estrogen use. A
new meta-analysis presented here extends these results to estrogen plus ... Cited by 518 - Related articles - BL Direct - All 9 versions
- ►uvm.edu [PDF] F Grodstein, TB Clarkson, JAE Manson - The New England journal of medicine, 2003 - nejm.highwire.org Recent findings from clinical trials examining the relation between
postmenopausal hormone therapy and coronary heart disease 1 , 2 have appeared to
be widely divergent from the results of earlier observational studies. In ... Cited by 258 - Related articles - BL Direct - All 6 versions
